Results 111 to 120 of about 729,299 (226)
, 2014 Soluble urokinase plasminogen activator receptor (suPAR) (ng/ml) in blood donors according to sex and age.
Christian Thorball (569556) +5 more
core +1 more source
Impact of endothelial activation on fibrinolysis and local proteolysis in tissue repair
, 1992 Chemicals/CAS: Cytokines; Plasminogen Activator Inhibitor 1; plasminogen activator, urokinase receptors; Plasminogen, 9001-91-6; Receptors, Cell Surface; Urinary Plasminogen Activator, EC 3.4.21 ...
Hinsbergh, V.W.M. van
core
Plasma Soluble Urokinase Plasminogen Activator Receptor in Children with Urinary Tract Infection
, 2011 Objective In this prospective study we investigated the role of plasma levels of soluble urokinase plasminogen activator receptor (suPAR) in children with urinary tract infection.
Lone Lindholm +7 more
core +1 more source
CAR T cell therapy beyond cancer: current status, challenges and future prospects
Signal Transduction and Targeted TherapyChimeric antigen receptor (CAR) T-cell therapy has revolutionized oncology, and its foundational logic—precise antigen recognition coupled with durable effector activity—extends naturally to chronic non-malignant diseases sustained by long-lived ...
Saurabh Upadhyay +3 more
doaj +1 more source
Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors [PDF]
The Journal of cell biology, 1987 Blasi, F. +2 more
openaire +3 more sources
, 2009 Video from Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung ...
Mario De Rosa (15040481) +12 more
core +1 more source
, 2015 Background. Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) play a key role in tumour invasion and metastasis. High levels of both proteolytic enzymes are associated with poor prognosis in breast cancer patients ...
Takac Iztok +8 more
core +1 more source
Urokinase -type Plasminogen Activator System in Human Breast Cancer [PDF]
, 2013 Urokinase plasminogen activator (uPA), urokinase plasminogen activator receptor (uPAR) and plasminogen activator inhibitor-1(PAI-1) are essential for metastasis, and overexpression of these molecules is strongly correlated with poor prognosis in a ...
Al-Rawi +4 more
core
Tristetraprolin inhibits the growth of human glioma cells through downregulation of urokinase plasminogen activator/urokinase plasminogen activator receptor mRNAs [PDF]
, 2015 Urokinase plasminogen activator (uPA) and urokinase plasminogen activator receptor (uPAR) play a major role in the infiltrative growth of glioblastoma. Downregulatoion of the uPA and uPAR has been reported to inhibit the growth glioblastoma.
Seokmin Kang +15 more
core